Indivior
↗Richmond, Virginia, United States
Indivior is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. Originally established as a division of Reckitt Benckiser in 1994, Indivior was demerged as a standalone company in December 2014. The company has evolved into a market leader in opioid addiction treatments with a rapidly expanding pipeline in substance use disorders including alcohol use disorder and cannabis use disorder. Headquartered in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in 37 countries worldwide.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Addiction Medicine / Opioid Use Disorder Treatment
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$1.1B-$1.2B
Founded:1994
Ownership:public
Status:operating
FUNDING
Stage:Public Company
STOCK
Exchange:NASDAQ
Ticker:INDV
Market Cap:$4.3B
PIPELINE
Stage:Phase 2-3
Lead Drug Stage:Commercial (SUBLOCADE generating $856M FY2025 revenue)
Modalities:Small molecule (buprenorphine, naloxone), Extended-release injectables, Sublingual films, Nasal spray (OPVEE)
Active Trials:67
Trial Phases:Phase 2: 15 | Phase 3: 5
FDA Approvals:8
EMA Approvals:3
CORPORATE STRUCTURE
Subsidiaries:Indivior UK Limited, Opiant Pharmaceuticals (acquired subsidiary)
Key Partnerships:Alar Pharmaceuticals - exclusive licensing for long-acting injectable buprenorphine formulations, C4X Discovery - orexin-1 receptor antagonist development (full rights acquired July 2023)
COMPETITION
Position:Leader
Competitors:Alkermes Inc (Vivitrol), Orexo AB (Brixadi - competitor LAI with 17% lower price), Teva Pharmaceutical, Pfizer, Collegium Pharmaceutical / BioDelivery Sciences, Camurus AB, Hikma Pharmaceuticals
LEADERSHIP
Key Executives:
Joseph Ciaffoni - Chief Executive Officer
David Wheadon - Chair
Patrick - Chief Commercial Officer
Ryan - Chief Financial Officer
Vanessa - Chief Corporate Affairs Officer
Ken Morici - Senior Vice President, Manufacturing and Supply
Scientific Founders:Howard Udell (Original Suboxone developer at Reckitt)
Board Members:David Wheadon (Chair)
LINKS
Website:indivior.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Indivior and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Indivior. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.